RTW Biotech Opp. - Holding(s) in Company
16/02/2024 16:50
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240216:nRSP5050Da&default-theme=true
RNS Number : 5050D RTW Biotech Opportunities Ltd 16 February 2024
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GG00BKTRRM22
Issuer Name
RTW BIOTECH OPPORTUNITIES LTD
UK or Non-UK Issuer
Non-UK
2. Reason for Notification
Other
Comments
As a result of the recent issuance of new ordinary shares of RTW Biotech
Opportunities Ltd ("RTW"), Bluestem's interest in RTW has been diluted to
8.74% which then triggers the notification threshold.
3. Details of person subject to the notification obligation
Name
Bluestem Asset Management, LLC
City of registered office (if applicable)
Charlottesville
Country of registered office (if applicable)
United States
Name City of registered office Country of registered office
Bluestem Partners, LP Wilmington Delaware USA
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s) subject to the
notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
13-Feb-2024
6. Date on which Issuer notified
16-Feb-2024
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached 8.740000 0.000000 8.740000 34093156
Position of previous notification (if applicable)
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible) Number of direct voting rights (DTR5.1) Number of indirect voting rights (DTR5.2.1) % of direct voting rights (DTR5.1) % of indirect voting rights (DTR5.2.1)
GG00BKTRRM22 34093156 0 8.740000 0.000000
Sub Total 8.A 34093156 8.740000%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument Expiration date Exercise/conversion period Number of voting rights that may be acquired if the instrument is % of voting rights
exercised/converted
Sub Total 8.B1
8B2. Financial Instruments with similar economic effect according to
(DTR5.3.1R.(1) (b))
Type of financial instrument Expiration date Exercise/conversion period Physical or cash settlement Number of voting rights % of voting rights
Sub Total 8.B2
9. Information in relation to the person subject to the notification
obligation
2. Full chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held starting with the
ultimate controlling natural person or legal entities (please add additional
rows as necessary)
Ultimate controlling person Name of controlled undertaking % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher Total of both if it equals or is higher than the notifiable threshold
than the notifiable threshold
Michael D. Bills Bluestem Asset Management LLC 8.740000 0.000000 8.740000%
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
Michael D. Bills has sole authority for Bluestem Asset Management, LLC, as its
Managing Member. Bluestem Asset Management, LLC is the General Partner of the
Shareholder, Bluestem Partners, LP, and is authorized to act for Bluestem
Partners, LP on all matters.
The last notification was submitted to the FCA and the issuer on 9/28/2020 via
email. Bluestem's interest in RTW Venture Fund Limited (as RTW Biotech
Opportunities Ltd was formerly known) held thru Vidacos Nominees Limited was
34,093,156 shares or around 18.96%.
12. Date of Completion
16/02/2024
13. Place Of Completion
Charlottesville, VA USA
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END HOLDZGMZVVRGDZM